Skip to content
10-Q

Quarterly Report

PONIARD PHARMACEUTICALS, INC.

0001193125-11-221165

← back to feed
Filed
Aug 12, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 5, 2011 59.94M sh
Capex Q2 2011 · Jun 30, 2011 $9K
Capex Q2 2011 · Jun 30, 2010 $0
Operating Cash Flow Q2 2011 · Jun 30, 2011 −$3.7M
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$15.36M
Cash And Equivalents Q2 2011 · Jun 30, 2011 $3.69M
Cash And Equivalents Q2 2011 · Dec 31, 2010 $1.28M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $10.2M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $15.94M
Stockholders Equity Q2 2011 · Jun 30, 2011 $6.28M
Stockholders Equity Q2 2011 · Dec 31, 2010 $8.45M
Current Liabilities Q2 2011 · Jun 30, 2011 $2.09M
Current Liabilities Q2 2011 · Dec 31, 2010 $1.62M
Current Assets Q2 2011 · Jun 30, 2011 $4.19M
Current Assets Q2 2011 · Dec 31, 2010 $5.22M
Total Assets Q2 2011 · Jun 30, 2011 $9.99M
Total Assets Q2 2011 · Dec 31, 2010 $11.64M
Sga Expense Q2 2011 · Jun 30, 2011 $3.4M
Sga Expense Q2 2011 · Jun 30, 2011 $6.3M
Sga Expense Q2 2011 · Jun 30, 2010 $3.89M
Sga Expense Q2 2011 · Jun 30, 2010 $8.69M
Rd Expense Q2 2011 · Jun 30, 2011 $442K
Rd Expense Q2 2011 · Jun 30, 2011 $775K
Rd Expense Q2 2011 · Jun 30, 2010 $2.09M
Rd Expense Q2 2011 · Jun 30, 2010 $6.98M
Net Income Q2 2011 · Jun 30, 2011 −$3.86M
Net Income Q2 2011 · Jun 30, 2011 −$7.1M
Net Income Q2 2011 · Jun 30, 2010 −$6.55M
Net Income Q2 2011 · Jun 30, 2010 −$18.44M
Operating Income Q2 2011 · Jun 30, 2011 −$3.84M
Operating Income Q2 2011 · Jun 30, 2011 −$7.07M
Operating Income Q2 2011 · Jun 30, 2010 −$5.98M
Operating Income Q2 2011 · Jun 30, 2010 −$17.29M